The U.S. Food and Drug Administration amended the terms of its emergency use authorizations for the Pfizer and Moderna bivalent vaccines on Tuesday, allowing people ages 65 and older and certain ...

The "bivalent" vaccine — meaning it targets two different antigens — is Moderna's leading candidate to have an effective booster ready for fall of 2022, the company said. "We are submitting ...

People hoping to get Moderna’s version of the new bivalent booster instead of Pfizer’s may have to travel — or wait a while to get their shot. “Moderna bivalent booster supply is ...

Full coverage of the Covid-19 pandemic Moderna has called the omicron bivalent vaccine its “lead candidate” for the fall. The new shot, called mRNA-1273.214, was tested in a Phase 2/3 ...

Or perhaps bivalent, bivalent, bivalent. Going forward, bivalent versions of the Pfizer/BioNTech and Moderna Covid-19 mRNA boosters are what’s going to be available, replacing the original ...

Were the original Moderna and Pfizer-BioNTech Covid-19 mRNA ... OK, so what about the new bivalent booster vaccines designed to protect against both the original SARS-CoV-2 and the BA.

Children 6 months through 5 years of age who received the original Moderna COVID-19 vaccine are now eligible to receive a single booster of the updated bivalent vaccine at least two months after ...

People hoping to get Moderna’s version of the new bivalent booster instead of Pfizer’s may have to travel — or wait a while to get their shot. “Moderna bivalent booster supply is temporarily delayed,” ...